NCT00250939
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Sophia Kinderziekenhuis, Erasmus MC Rotterdam, Netherlands
Clinical trial condition
Glycogen Storage Disease Type II
Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.
105 public trials
19 recruiting studies
Glycogen Storage Disease Type II trial results
Completed
Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease
NCT00074932
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Colorado Health Science Center Aurora, Colorado, United States
- Galichia Heart Hospital Wichita, Kansas, United States
- Genzyme Medical Information Cambridge, Massachusetts, United States
- Freeman Health Systems Joplin, Missouri, United States
NCT00125879
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Shands Hospital at the University of Florida Gainesville, Florida, United States
- Miami Children's Hospital Miami, Florida, United States
- Emory University Medical Genetics Decatur, Georgia, United States
NCT00053573
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
- Locations
-
- University of Florida College of Medicine Gainesville, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
- Children's Hospital Medical Center Cincinnati, Ohio, United States
- Pediatrique Hopital de Brousse Lyon, France
NCT00763932
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Children's Hospital of Oakland Oakland, California, United States
- Children's Hospital of Orange Country Orange, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Institute for Genetic Medicine, Saint Peter's University Hospital New Brunswick, New Jersey, United States
Completed
A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease
NCT00059280
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- University of Florida College of Medicine Gainesville, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
- Children's Hospital Medical Center Cincinnati, Ohio, United States
- University of Utah Medical Center Salt Lake City, Utah, United States
NCT00051935
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
- Locations
-
- Saint Peter's University Hospital New Brunswick, New Jersey, United States
NCT00268944
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Hopital Raymond Poincare Garches, France
NCT01758354
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT00830583
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Claude Desnuelle Nice, France
Related conditions
- Brain Diseases (105)
- Brain Diseases, Metabolic (105)
- Brain Diseases, Metabolic, Inborn (105)
- Carbohydrate Metabolism, Inborn Errors (105)
- Central Nervous System Diseases (105)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (105)
- Genetic Diseases, Inborn (105)
- Lysosomal Storage Diseases, Nervous System (105)